EUVIMEDEUVIMED entdecken
Klinische Studie (Phase III)VergleichsstudieMultizentrische StudieRandomisierte kontrollierte StudieOpen Access · CC BY-NC 4.0

Comparative Efficacy of Potassium-Competitive Acid Blocker-Based Triple Therapy with Tegoprazan versus Vonoprazan for Helicobacter pylori Eradication: A Randomized, Double-Blind, Active-Controlled Pilot Study

Jae Yong Park iD, Il Ju Choi iD, Gwang Ha Kim iD, Su Jin Hong iD, Sung Kwan Shin iD, Seong Woo Jeon iD, Jae Gyu Kim iD

Gut and Liver · 2025

DOI: 10.5009/gnl250067 ↗

Kurz gefasst

Klinische Studie (Phase III) in der Zeitschrift Gut and Liver, 2025. Verfasst von Jae Yong Park und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Helicobacter Infections, Helicobacter pylori, Proton Pump Inhibitors. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: HK inno.N Corp..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsHelicobacter InfectionsHelicobacter pyloriProton Pump InhibitorsPyrrolesSulfonamidesAdultAgedFemaleHumansMaleMiddle AgedAmoxicillinClarithromycinDouble-Blind MethodDrug Therapy, CombinationPilot ProjectsTreatment Outcome

Stichwörter der Autor:innen

AntibioticsClinical trialsHelicobacter pylorirandomized

Substanzen

1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamineAmoxicillinAnti-Bacterial AgentsClarithromycinProton Pump InhibitorsPyrrolesSulfonamides

Autor:innen und Institutionen

  • Division of Gastroenterology, Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea.
  • Center for Gastric Cancer, National Cancer Center, Goyang, Korea.
  • Department of Internal Medicine, Pusan National University School of Medicine and Biomedical Research Institute, Pusan National University Hospital, Busan, Korea.
  • Department of Internal Medicine, Digestive Disease Center and Research Institute, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea.
  • Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
  • Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Korea.

ORCID-Profile: Jae Yong Park, Il Ju Choi, Gwang Ha Kim, Su Jin Hong, Sung Kwan Shin, Seong Woo Jeon, Jae Gyu Kim

Förderung

  • HK inno.N Corp.

Zitieren

APA

Park, J. Y., Choi, I. J., Kim, G. H., Hong, S. J., Shin, S. K., Jeon, S. W., & Kim, J. G. (2025). Comparative Efficacy of Potassium-Competitive Acid Blocker-Based Triple Therapy with Tegoprazan versus Vonoprazan for Helicobacter pylori Eradication: A Randomized, Double-Blind, Active-Controlled Pilot Study. Gut and Liver. https://doi.org/10.5009/gnl250067

Vancouver

Park JY, Choi IJ, Kim GH, Hong SJ, Shin SK, Jeon SW, et al. Comparative Efficacy of Potassium-Competitive Acid Blocker-Based Triple Therapy with Tegoprazan versus Vonoprazan for Helicobacter pylori Eradication: A Randomized, Double-Blind, Active-Controlled Pilot Study. Gut and Liver. 2025. doi:10.5009/gnl250067

BibTeX
@article{Park2025,
  author = {Park, Jae Yong and Choi, Il Ju and Kim, Gwang Ha and Hong, Su Jin and Shin, Sung Kwan and Jeon, Seong Woo and Kim, Jae Gyu},
  title = {Comparative Efficacy of Potassium-Competitive Acid Blocker-Based Triple Therapy with Tegoprazan versus Vonoprazan for Helicobacter pylori Eradication: A Randomized, Double-Blind, Active-Controlled Pilot Study},
  journal = {Gut and Liver},
  year = {2025},
  doi = {10.5009/gnl250067}
}
Kostenlos starten →